NEWS

Our Latest News

ARCHIMED’s sale of Polyplus to Sartorius Stedim earns 300x for MED I, an all-time record return for a private equity investment
ARCHIMED’s sale of Polyplus to Sartorius Stedim earns 300x for MED I, an all-time record return for a private equity investment

ARCHIMED invests in Title21 Health Solutions, a leading US-based healthcare software provider

 July

 12, 

2022

ARCHIMED invests in Corealis Pharma, a North American CDMO, through MED III

 May

 24, 

2022

ARCHIMED’s MED II fund earns a 6x return on EUROLyser, its first exit

 May

 9, 

2022

ARCHIMED sells health ingredients developer Fytexia to Associated British Foods

 February

 2, 

2022

ARCHIMED buys CARSO, a leader in purity testing for pharma and other industries

 December

 16, 

2021

ARCHIMED reaches agreement to sell Bomi Group to UPS

 December

 16, 

2021

1 2 3 4 5 … 13
368